Source: University Of Queensland
Posted: April 14, 2006
Researchers are developing a drug that targets liver cells to prevent their inflammation in obesity -- a common precursor to diabetes.
The technique involved coating treatment drugs in absorbable fat which formed an injectable dose that could last up to one week. The goal of the treatment is to encapsulate curcumin, an anti-inflammatory compound found in curries, and then deliver it to the liver cells to prevent them from producing inflammatory compounds.
If successful, the treatment could combat other diseases such as heart disease, osteoarthritis, rheumatoid arthritis and lupus, an autoimmune disease against the skin.
Commentary: This is an innovative new approach to treating diabetes. Maybe similar approaches could lead to the development of drugs to treat other diseases.
No comments:
Post a Comment